Kindeva Drug Delivery
This role focuses on the method development and validation for transdermal patches and topical formulations, including assay, dissolution, and residual solvents testing. The position involves executing in vitro release and permeation testing using Franz diffusion cells, as well as conducting deformulation and reverse engineering studies. Additionally, the role requires characterizing physical and adhesive properties of transdermal systems and preparing technical documentation.
Headquarters
Woodbury, Minnesota, United States
Company Size
1001-5000 employees
Founded
2020
Kindeva is a drug-delivery focused CDMO that specializes in developing and manufacturing drug–device combination products. They provide end-to-end services—from formulation and device design through clinical and commercial-scale manufacturing—supporting pharmaceutical and biotech customers with technical, quality, and regulatory expertise. Purpose‑fueled and people‑centric, Kindeva emphasizes collaborative partnerships and practical experience to advance clients’ projects and bring complex delivery solutions to market.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Kindeva Drug Delivery.
Kindeva Drug Delivery didn’t post a salary, so this is our estimate from similar listings.
Sciences Analytiques – Expert en Dissolution / Principal scientist
Sanofi
Scientist, Dissolution
PerkinElmer
Dissolution Analytical Development Lead
BioLife Plasma Services
Associate Formulations Scientist
Eurofins
Scientist, Standards/Dissolution/Mastication
PerkinElmer
Research and Development Scientist
Nephron Pharmaceuticals